Pharos Capital Invests in Renal Care 360°

Pharos Capital Invests in Sanderling Renal Services

May 16, 2022

Healthcare Services

Pharos Capital Group made a significant growth investment in Sanderling Renal Services to support expansion of the company's home dialysis operations, telemedicine and hospital eDialysis contracts, and geographic growth via acquisitions and de novo clinics. Sanderling, headquartered in Nashville, Tennessee, operates 14 clinics across six states and provides tele-nephrology and acute eDialysis services to 30+ partner hospitals; terms were not disclosed.

Carrick Capital Partners Invests in Renalogic (Growth Recapitalization)

March 3, 2021

Healthcare Services

Carrick Capital Partners has made a growth recapitalization investment in Renalogic, a provider of dialysis risk management and chronic kidney disease (CKD) cost-containment solutions. The investment will support Renalogic's expansion of services — including its predictive analytics/AI platform CareINSIGHTS.ai — to scale support for self-funded employers, health plans and stop-loss carriers.

Investor Group Led by Chris Brengard and Management (with Bain, Summit, Revelstoke, Mark Caputo) Acquires U.S. Renal Care

February 13, 2019

Healthcare Services

U.S. Renal Care, a Plano, Texas-based provider of dialysis services, entered into a definitive agreement to be acquired by a private investor group led by CEO Chris Brengard and the U.S. Renal management team alongside Bain Capital Private Equity, Summit Partners, Revelstoke Capital Partners, and investor Mark Caputo. The management team will remain significant investors; financial terms were not disclosed and the transaction remains subject to customary closing conditions and regulatory approvals.

Pharos Capital Makes Majority Investment in RhythMedix

January 4, 2024

Medical Devices

Pharos Capital Group has acquired a majority stake in RhythMedix, a Mount Laurel, New Jersey-based maker of wearable cardiac monitoring devices and related services. RhythMedix's management is reinvesting and will remain in place; Pharos plans to support growth through increased R&D, market share expansion, and add-on acquisitions to broaden remote patient monitoring capabilities.

Quadria Capital Leads $102M Investment in NephroPlus; Investcorp Partially Exits

May 7, 2024

Healthcare Services

Quadria Capital led a $102 million funding round in NephroPlus that combines primary capital and a secondary purchase of stakes from existing investors, including Investcorp, Bessemer Venture Partners, IFC and IIFL Private Equity. Investcorp retains a significant minority stake; the new capital will be used to fund organic growth in India and further international expansion of NephroPlus, Asia's largest dialysis service network headquartered in Hyderabad.

Pharos Capital Acquires Vantage Outsourcing to Build Ophthalmology Services Platform

September 22, 2021

Healthcare Services

Pharos Capital Group has acquired Vantage Outsourcing, a cataract surgical support services provider headquartered in Effingham, Illinois. Pharos will partner with industry executive Bradley Hill and work with Vantage's existing leadership—co-founder and CEO Ann Deters and President Chris Swing (who retain minority stakes)—to build a broader surgical support services platform across ophthalmology and other specialties.